HealthStream (HSTM) Competitors

Omnicell (NASDAQ:OMCL) and HealthStream (NASDAQ:HSTM) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, community ranking, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Is OMCL or HSTM more profitable?

HealthStream has a net margin of 6.84% compared to Omnicell's net margin of 1.13%. HealthStream's return on equity of 5.67% beat Omnicell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omnicell	1.13%	3.82%	2.07%
HealthStream	6.84%	5.67%	3.91%

Do analysts rate OMCL or HSTM?

Omnicell currently has a consensus target price of $46.50, suggesting a potential upside of 61.57%. HealthStream has a consensus target price of $31.50, suggesting a potential upside of 9.95%. Given Omnicell's higher probable upside, analysts clearly believe Omnicell is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omnicell	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
HealthStream	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80

Does the media prefer OMCL or HSTM?

In the previous week, Omnicell had 4 more articles in the media than HealthStream. MarketBeat recorded 18 mentions for Omnicell and 14 mentions for HealthStream. Omnicell's average media sentiment score of 1.20 beat HealthStream's score of 0.71 indicating that Omnicell is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omnicell	8 Very Positive mention(s)	6 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthStream	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, OMCL or HSTM?

Omnicell has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500. Comparatively, HealthStream has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500.

Does the MarketBeat Community believe in OMCL or HSTM?

Omnicell received 43 more outperform votes than HealthStream when rated by MarketBeat users. Likewise, 66.75% of users gave Omnicell an outperform vote while only 66.43% of users gave HealthStream an outperform vote.

Company	Underperform	Outperform
Omnicell	Outperform Votes 506 66.75%	Underperform Votes 252 33.25%
HealthStream	Outperform Votes 463 66.43%	Underperform Votes 234 33.57%

Do institutionals and insiders hold more shares of OMCL or HSTM?

97.7% of Omnicell shares are owned by institutional investors. Comparatively, 69.6% of HealthStream shares are owned by institutional investors. 2.5% of Omnicell shares are owned by company insiders. Comparatively, 20.6% of HealthStream shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Which has stronger valuation & earnings, OMCL or HSTM?

HealthStream has lower revenue, but higher earnings than Omnicell. HealthStream is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omnicell	$1.14B	1.19	$12.53M	$0.46	62.57
HealthStream	$292.37M	2.99	$15.21M	$0.63	45.48

Summary

Omnicell beats HealthStream on 10 of the 19 factors compared between the two stocks.